SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB: NVLX) announced today it has signed a definitive agreement to acquire all of the assets and technologies of SG Austria Pte. Ltd., the world’s leading live-cell-encapsulation company. SG Austria’s technology permits the safe use of cells for the treatment of multiple human diseases and will dramatically enhance biotechnology and research development that is dependent on cellular products.
